Skip to content

Clinical trials

Terminated Observational Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Observational Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20131
20141
20151
20161
20171
20191
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Geneva Foundation2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Cambridge University Hospitals NHS Foundation Trust1
Columbia University1
Duke University1
National Human Genome Research Institute (NHGRI)1
Rigshospitalet, Denmark1
Viome1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease11
Coronary Artery Disease2
Liver Cirrhosis2
Obesity2
Barrett Esophagus1
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Celiac Disease1
Cholelithiasis1
Colitis, Lymphocytic1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.